Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T674I mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy [3]

British Journal of Haematology

Volumn 134, Issue 5, 2006, Pages 547-549

  Ohnishi, Hiroaki ^a   Kandabashi, Koji ^b   Maeda, Yoshiharu ^b   Kawamura, Machiko ^b   Watanabe, Takashi ^a  

^a KYORIN UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Hypereosinophilic syndrome; Imatinib; Resistant; Secondary leukaemia; Tyrosine kinase

Indexed keywords

CLADRIBINE; DNA; IMATINIB; MERCAPTOPURINE; METHOTREXATE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; RNA; VINBLASTINE;

CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHRONIC LEUKEMIA; DISEASE COURSE; EOSINOPHILIA; EOSINOPHILIC LEUKEMIA; FIP1L1 PDGFRA FUSION GENE; FUSION GENE; GENE MUTATION; HISTIOCYTOSIS X; HUMAN; LETTER; PLEURA EFFUSION; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; CHRONIC DISEASE; DISEASE PROGRESSION; EOSINOPHILIA; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MUTATION; ONCOGENE PROTEINS, FUSION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33746473457     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06221.x     Document Type: Letter

References (4)

1. Cools, J., DeAngelo, D.J., Gotlib, J., Stover, E.H., Legare, R.D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J.D., Cross, N.C., Tefferi, A., Malone, J., Alam, R., Schrier, S.L., Schmid, J., Rose, M., Vandenberghe, P., Verhoef, G., Boogaerts, M., Wlodarska, I., Kantarjian, H., Marynen, P., Coutre, S.E., Stone, R. & Gilliland, D.G. (2003a) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. New England Journal of Medicine, 348, 1201-1214.
2. Cools, J., Stover, E.H., Boulton, C.L., Gotlib, J., Legare, R.D., Amaral, S.M., Curley, D.P., Duclos, N., Rowan, R., Kutok, J.L., Lee, B.H., Williams, I.R., Coutre, S.E., Stone, R.M., DeAngelo, D.J., Marynen, P., Manley, P.W., Meyer, T., Fabbro, D., Neuberg, D., Weisberg, E., Griffin, J.D. & Gilliland, D.G. (2003b) PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease. Cancer Cell, 3, 459-469.
3. Griffin, J.H., Leung, J., Bruner, R.J., Caligiuri, M.A. & Briesewitz, R. (2003) Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proceedings of the National Academy of Sciences of the United States of America, 100, 7830-7835.
4. Tanaka, Y., Kurata, M., Togami, K., Fujita, H., Watanabe, N., Matsushita, A., Maeda, A., Nagai, K., Sada, A., Matsui, T. & Takahashi, T. (2006) Chronic eosinophilic leukemia with the FIP1L1-PDGFRal-pha fusion gene in a patient with a history of combination chemotherapy. International Journal of Hematology, 83, 152-155.